본문 바로가기
KERD
논문KCI 등재

Predictors of Poor Outcome in Patients with Acute Cerebral Infarction

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Background and Purpose Plasma D-dimer levels are elevated during the acute phase of cerebral infarction (CI). We investigated whether the D-dimer level on admission and other clinical characteristics could be used to predict the poor outcome of patients with acute CI. Methods The clinical characteristics and plasma D-dimer levels measured within 3 days of onset were compared according to outcome among patients with acute CI. Results In total, 359 consecutive patients (mean age, 71.8 years) were examined, of which 174 had a poor outcome [score on the modified Rankin scale (mRS) ≥3] at 30 days after hospitalization. The mean mRS score was higher and a poor outcome was observed more frequently among women than among men (p<0.001 for each). The proportions of women, cardioembolism, atrial fibrillation, advanced age (≥75 years), prior history of CI or transient ischemic attack, and elevated D-dimer level (≥1.0 μg/mL) were significantly higher among patients with a poor outcome than among those with a good outcome. A multivariate analysis showed that elevated D-dimer level [≥1.0 μg/mL; odds ratio (OR), 2.45; 95% confidence interval (95% CI),1.52-3.89; p<0.01], advanced age (OR, 1.93; 95% CI, 1.21-3.07; p<0.01), and female gender (OR, 1.75; 95% CI, 1.08-2.83; p=0.02) were independent predictors of a poor outcome. Conclusions Certain clinical characteristics (gender and advanced age) and an elevated Ddimer level upon admission can be used to predict the outcome of patients with acute CI at 30 days after hospitalization.

Abstract

Background and Purpose Plasma D-dimer levels are elevated during the acute phase of cerebral infarction (CI). We investigated whether the D-dimer level on admission and other clinical characteristics could be used to predict the poor outcome of patients with acute CI. Methods The clinical characteristics and plasma D-dimer levels measured within 3 days of onset were compared according to outcome among patients with acute CI. Results In total, 359 consecutive patients (mean age, 71.8 years) were examined, of which 174 had a poor outcome [score on the modified Rankin scale (mRS) ≥3] at 30 days after hospitalization. The mean mRS score was higher and a poor outcome was observed more frequently among women than among men (p<0.001 for each). The proportions of women, cardioembolism, atrial fibrillation, advanced age (≥75 years), prior history of CI or transient ischemic attack, and elevated D-dimer level (≥1.0 μg/mL) were significantly higher among patients with a poor outcome than among those with a good outcome. A multivariate analysis showed that elevated D-dimer level [≥1.0 μg/mL; odds ratio (OR), 2.45; 95% confidence interval (95% CI),1.52-3.89; p<0.01], advanced age (OR, 1.93; 95% CI, 1.21-3.07; p<0.01), and female gender (OR, 1.75; 95% CI, 1.08-2.83; p=0.02) were independent predictors of a poor outcome. Conclusions Certain clinical characteristics (gender and advanced age) and an elevated Ddimer level upon admission can be used to predict the outcome of patients with acute CI at 30 days after hospitalization.

참고문헌 (43)

  1. Kitamura A, "Trends in the incidence of coronary heart disease and stroke and the prevalence of cardiovascular risk factors among Japanese men from 1963 to 1994", Am J Med, 112, pp.104~109 (2002)
  2. Appelros P, "Poor outcome after first-ever stroke: predictors for death, dependency, and recurrent stroke within the first year", Stroke, 34, pp.122~126 (2003)
  3. Di Carlo A, "Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry", Stroke, 34, pp.1114~1119 (2003)
  4. Howard G, "Community Hospital-based Stroke Programs: North Carolina, Oregon, and New York. III. Factors influencing survival after stroke: proportional hazards analysis of 4219 patients", Stroke, 17, pp.294~299 (1986)
  5. Turaj W, "Gender-related differences in diagnostic evaluation and outcome of ischemic stroke in Poland", Stroke, 40, pp.980~982 (2009)
  6. Lewsey JD, "Sex differences in incidence, mortality, and survival in individuals with stroke in Scotland, 1986 to 2005", Stroke, 40, pp.1038~1043 (2009)
  7. Appelros P, "Sex differences in stroke epidemiology: a systematic review", Stroke, 40, pp.1082~1090 (2009)
  8. Eriksson M, "Sex differences in stroke care and outcome in the Swedish national quality register for stroke care", Stroke, 40, pp.909~914 (2009)
  9. Smith DB, "Gender differences in the Colorado Stroke Registry", Stroke, 40, pp.1078~1081 (2009)
  10. Reid JM, "Gender differences in stroke examined in a 10-year cohort of patients admitted to a Canadian teaching hospital", Stroke, 39, pp.1090~1095 (2008)
  11. Fukuda M, "Gender differences in long-term functional outcome after first-ever ischemic stroke", Intern Med, 48, pp.967~973 (2009)
  12. Petrea RE, "Gender differences in stroke incidence and poststroke disability in the Framingham heart study", Stroke, 40, pp.1032~1037 (2009)
  13. Dougu N, "Differential diagnosis of cerebral infarction using an algorithm combining atrial fibrillation and D-dimer level", Eur J Neurol, 15, pp.295~300 (2008)
  14. Barber M, "D-dimer predicts early clinical progression in ischemic stroke: confirmation using routine clinical assays", Stroke, 37, pp.1113~1115 (2006)
  15. Welsh P, "Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke", Cerebrovasc Dis, 27, pp.247~253 (2009)
  16. Tombul T, "Hemostatic markers and platelet aggregation factors as predictive markers for type of stroke and neurological disability following cerebral infarction", J Clin Neurosci, 12, pp.429~434 (2005)
  17. Squizzato A, "D-dimer is not a long-term prognostic marker following acute cerebral ischemia", Blood Coagul Fibrinolysis, 17, pp.303~306 (2006)
  18. Di Napoli M, "Villa Pini Stroke Data Bank Investigators. Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients", Stroke, 33, pp.1763~1771 (2002)
  19. Rallidis LS, "Usefulness of inflammatory and haemostatic markers to predict short-term risk for death in middle-aged ischaemic stroke patients", Acta Neurol Scand, 117, pp.415~420 (2008)
  20. Lip GY, "Sequential alterations in haemorheology, endothelial dysfunction, platelet activation and thrombogenesis in relation to prognosis following acute stroke: The West Birmingham Stroke Project", Blood Coagul Fibrinolysis, 13, pp.339~347 (2002)
  21. Gage BF, "Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation", JAMA, 285, pp.2864~2870 (2001)
  22. Adams HP Jr, "Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment", Stroke, 24, pp.35~41 (1993)
  23. van Swieten JC, "Interobserver agreement for the assessment of handicap in stroke patients", Stroke, 19, pp.604~607 (1988)
  24. Jüttler E, "Long-term outcome after surgical treatment for space-occupying cerebellar infarction: experience in 56 patients", Stroke, 40, pp.3060~3066 (2009)
  25. Ueda T, "Multivariable analysis of predictive factors related to outcome at 6 months after intra-arterial thrombolysis for acute ischemic stroke", Stroke, 30, pp.2360~2365 (1999)
  26. Whiteley W, "Blood markers for the prognosis of ischemic stroke: a systematic review", Stroke, 40, pp.380~389 (2009)
  27. Herman B, "Epidemiology of stroke in Tilburg, the Netherlands. The population-based stroke incidence register: 2. Incidence, initial clinical picture and medical care, and three-week case fatality", Stroke, 13, pp.629~634 (1982)
  28. Brønnum-Hansen H, "Danish MONICA Study Group. Long-term survival and causes of death after stroke", Stroke, 32, pp.2131~2136 (2001)
  29. Roquer J, "Sex differences in first-ever acute stroke", Stroke, 34, pp.1581~1585 (2003)
  30. Glader EL, "Sex differences in management and outcome after stroke: a Swedish national perspective", Stroke, 34, pp.1970~1975 (2003)
  31. Gray LJ, "Sex differences in quality of life in stroke survivors: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST)", Stroke, 38, pp.2960~2964 (2007)
  32. Paolucci S, "Is sex a prognostic factor in stroke rehabilitation? A matched comparison", Stroke, 37, pp.2989~2994 (2006)
  33. Takano K, "Markers of a hypercoagulable state following acute ischemic stroke", Stroke, 23, pp.194~198 (1992)
  34. Kataoka S, "Activation of thrombosis and fibrinolysis following brain infarction", J Neurol Sci, 181, pp.82~88 (2000)
  35. Feinberg WM, "Hemostatic markers in acute ischemic stroke. Association with stroke type, severity, and outcome", Stroke, 27, pp.1296~1300 (1996)
  36. Montaner J, "Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers", Stroke, 39, pp.2280~2287 (2008)
  37. Berge E, "Hemostatic activation in acute ischemic stroke", Thromb Res, 101, pp.13~21 (2001)
  38. Ageno W, "Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes", Arch Intern Med, 162, pp.2589~2593 (2002)
  39. Fisher M, "Altered coagulation in cerebral ischemia. Platelet, thrombin, and plasmin activity", Arch Neurol, 47, pp.1075~1079 (1990)
  40. Tohgi H, "Coagulation-fibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism", Stroke, 21, pp.1663~1667 (1990)
  41. Ay H, "Admission international normalized ratio and acute infarct volume in ischemic stroke", Ann Neurol, 64, pp.499~506 (2008)
  42. Wakita M, "Effects of anticoagulation on infarct size and clinical outcome in acute cardioembolic stroke", Angiology, 53, pp.551~556 (2002)
  43. Jin L, "Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase", Clin Hemorheol Microcirc, 23, pp.213~218 (2000)

관련 논문AI추천

이 간행물의 다른 논문 (9건)